+ neurotoxicity by a cell-to-cell contact mechanism underlying CD47-SIRPA interaction and Rac1/Akt activation.
Introduction
Accumulating evidence indicates that T lymphocytes are involved in neuroimmune activities in the brain of Parkinson's disease (PD), a neurodegenerative disease characterized by progressive degeneration of dopaminergic neurons in the nigrostriatal system [1] [2] [3] . T lymphocytes infiltrate into the brain and locate around degenerating dopaminergic neurons with activated microglia in both patients with PD and models of PD [4] [5] [6] . Since T lymphocytes have several subpopulations that play different roles in immune responses, they may exert different effects in PD processes. For example, T helper (Th)17 cells, the pro-inflammatory CD4 +
CD25
-T lymphocytes, exacerbate PD pathology and symptoms by promoting microglial excessive activation or by directly damaging dopaminergic neurons in our and other reports [6, 7] . Regulatory T (Treg) cells, the Foxp3-expressing CD4 + CD25 + T lymphocytes, are originally termed "suppressor cells" [8] and are pivotal in suppressing autoimmunity and maintaining immune homeostasis [9, [10] [11] [12] . A growing body of evidence shows that Treg cells are not only important for maintaining immune balance at the periphery but also contribute to self-tolerance and immune privilege in the central nervous system [13] . Treg cells isolated from PD patients show decreased ability to suppress function of effector T cells from healthy allogeneic donors, suggesting a dysfunction of Treg cells during PD progression [14] . Adoptive transfer of CD3-activated Treg cells to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice provides greater than 90% protection of the nigrostriatal system, and the neuroprotection of Treg cells is achieved through suppression of microglial oxidative stress and inflammation [15] . Combinations of adoptively transferred nitrated alpha-synuclein and Treg cells to MPTP mice attenuate microglial inflammatory responses and lead to robust nigrostriatal protection [6] . These reports support a notion that Treg cells implement neuroprotection through inhibition of microglial inflammatory responses. Therefore we questioned whether Treg cells directly act on dopaminergic neurons to exert neuroprotection in PD processes.
Animal cells communicate with each other in two principal ways: 1) they secrete chemicals that signal to cells at some distance; and 2) they express a signaling molecule at the cell surface that binds to a cognate receptor on adjacent cells [16] . Treg cells suppress inflammatory and immune responses by secreting anti-inflammatory cytokines such as transforming growth factor (TGF)-β1 and interleukin (IL)-10 [17, 18] . This regulatory way of Treg cells belongs to the first communication system. In the brain, the anti-inflammatory cytokines impair inflammatory milieu and glial activation but enhance the stabilization of the blood-brain barrier, and therefore they have neuroprotective properties [19, 20] . Nevertheless, the anti-inflammatory cytokine TGF-β1 does not directly act on dopaminergic neurons to protect them against the toxicity of 1-methyl-4-phenylpyridinium (MPP + ), a toxic cation that is concentrated in dopaminergic neurons via presynaptic dopamine transporters to kill the neurons, in our recent study [19] . We have demonstrated that microglia are required for mediation of TGF-β1 neuroprotection against MPP + toxicity [19] . Thus, the second communication way between Treg cells and dopaminergic neurons was investigated in the present study to better understand the rationality of Treg cell neuroprotection.
One recently identified cell-cell communication system is composed of the transmembrane proteins CD47 and signal regulatory protein α (SIRPA) [16] . CD47 is widely expressed in most cell types and functions as a ligand for SIRPA [21, 22] . SIRPA is especially abundant in neurons and in macrophages, dendritic cells and neutrophils [23] [24] [25] . Interaction of CD47 with SIRPA occurs between host-derived cells, and is mostly related to cell signaling in the immune and nervous systems [16] . For example, upon binding CD47, SIRPA on macrophages initiates a signaling cascade that results in inhibition of phagocytosis by the cells [21] . Activation of SIRPA through interaction with CD47 also regulates development of dendritic cells and neuronal network formation [16, 26] . However, whether the interaction of CD47 on Treg cells with SIRPA on dopaminergic neurons mediates a neuroprotection of Treg cells needs clarification.
Ligation of SIRPA by CD47 promotes tyrosine phosphorylation of the former protein in macrophages [27, 28] and endothelial cells [25] . Upon phosphorylation, SIRPA activates Src homology-2 (SH2) domain containing protein phosphatases SHP-1 and/or SHP-2 [29] . SHP-2 regulates function of small GTP-binding proteins, Ras and Rho [16] . Rac1, a Rho family GTPase, participates in regulation of cytoskeletal reorganization, cellular growth, and apoptosis via activation of downstream signaling such as Akt, a serine/threonine kinase [30, 31] . Thus, the signaling pathway Rac1/Akt in neurons was also examined in this study to explain an involvement of the intracellular transducer in CD47/SIRPA-mediated Treg cell neuroprotection.
Accordingly, in the present study, we firstly demonstrated that Treg cells prevented MPP + -induced dopaminergic neuronal loss and glial mediator disorders in ventral mesencephalic (VM) cell cultures; secondly we identified that the cytokines TGF-β1 and IL-10 secreted from Treg cells that were co-cultured with VM neurons via a transwell system did not significantly protect dopaminergic neurons against MPP + toxicity; thirdly we established that CD47-SIRPA interaction mediated Treg cell contact protection to dopaminergic neurons; and lastly we showed that neuronal Rac1/Akt signaling transduced the information of CD47-SIRPA interaction-mediated Treg cell neuroprotection.
Materials and Methods

Primary VM cell culture
The preparation of VM cells was based on a previously described method [32] . Anesthetized pregnant C57BL/6J mice on embryonic day 13 ± 0.5 (E13 ± 0.5) were decapitated and embryonic pups were removed aseptically. The VM tissues of embryos were collected, washed with Hank's Balanced Salt Solution (HBSS) at 4°C, and incubated in 2 ml of pre-warmed 2.5 mg/ml trypsin solution (Gibco, USA) for 12 min at 37°C. Cells were subsequently centrifuged and resuspended in complete DMEM medium (Invitrogen, USA) containing 10% fetal bovine serum (Invitrogen, USA). Cell suspensions were plated onto poly-D-lysine-coated 24-well plates or 6-well plates at a density of 5 × 10 5 cells/cm 2 , which were incubated at 37°C in a humidified 5% CO 2 /95% air atmosphere incubator (Thermo 8000WJ, USA). The seven-day-old cultures were used in subsequent experiments.
Primary VM neuron-enriched culture
To inhibit glial proliferation, cytosine arabinoside (10 μM) was added to primary VM cell cultures that were described above at 24 h after the cells were plated. The cultures were considered as VM neuronenriched cultures. The six-day-old neuron-enriched cultures, which contain >90% NeuN-immunoreactive neurons [33] , were employed in subsequent experiments.
Isolation and culture of Treg cells
The protocol followed the instructions of CD4 +
CD25
+ Treg cell isolation kit (Miltenyi Biotec, Germany). Briefly, C57BL/6J mice were sacrificed after deep anesthesia, and single-cell suspensions were prepared from the spleens. CD4
+ T cell populations from the spleens were enriched by negative selection and CD4 
Foxp3
+ cells accounted for 93-95%, which is consistent with the report [34] . To activate Treg cells, the cells were incubated with 2 μg/ml anti-CD3 and 2 μg/ml anti-CD28 (both from BD Biosciences, USA) for 4 days at a density of 1 × 10 6 cells/ml in complete RPMI 1640 (Invitrogen, USA) supplemented with 10% FBS, 2 mM L-glutamine, 25 mM HEPES, 1 mM sodium pyruvate, 13 nonessential amino acids, 55 nM 2-ME, 100 U/ml penicillin, and 100 mg/ml streptomycin (Gibco, USA).
Co-culture of Treg cells with VM cells or VM neurons
Activated Treg cells were rinsed and resuspended in complete DMEM medium, which was added to seven-day-old VM cell cultures or seven-day-old VM neuron cultures at a ratio of 1:1. After Treg cells were co-cultured with VM cells or VM neurons for 1 h, MPP + (Sigma, USA) was applied to the co-cultures at a concentration of 5 μM. After 24 h of incubation, the co-cultures were washed with PBS to removed Treg cells. The remaining VM cells or VM neurons were subjected to subsequent analysis.
Transwell co-culture of Treg cells and VM neurons
Activated Treg cells were rinsed and resuspended in complete DMEM medium at a density of 5 × 10 5 cells/ml, which was transferred into a transwell cell culture chamber, bottom of which was comprised of a membrane with 0.4-μm pore size (Millipore, USA). The transwell chamber containing Treg cells was placed into the 24-well culture plate containing seven-day-old VM neurons. The ratio of Treg cells to VM neurons was 1:1. After co-culture for 1 h, MPP + (Sigma, USA) was applied to VM neurons in the lower 24-well plate at a concentration of 5 μM. After 24 h of incubation, the transwell chamber was removed, and the supernatants and the neurons in the lower 24-well plate were collected to detect cytokine levels and neuronal number, respectively. 
RNA isolation and real-time PCR assays
Western blotting analysis
The co-cultures of Treg cells with VM cells or VM neurons were washed with 0.01 M PBS to remove the suspended Treg cells. Proteins in the remaining VM cells or VM neurons were extracted with lysis buffer (62.5 mM Tris-HCl at pH 6.8, 2% SDS, 4% β-mercaptoethanol, 10% glycerol, 50 mM DTT, and 1 mM phenylmethanesulfonyl). Protein samples (30 μg per lane) were fractionated by SDS-PAGE on 12% gels, and were then transferred onto polyvinylidene difluoride membranes (Millipore, USA). The membranes were probed using antibodies against TNF-α (1:400, Abcam, UK), IL-1β (1:200, Santa Cruz Biotechnology, USA), GDNF (1:500, Abcam, UK), IGF-1 (1:200, Santa Cruz Biotechnology, USA), phosphor-Akt (1:1000, Cell Signaling, USA), Bcl-xL (1:1000, Cell Signaling, USA), or cleaved caspase-3 (1:1000, Cell Signaling, USA). Monoclonal anti-β-actin antibody was included as an internal standard to monitor loading errors. Appropriate IRDye 800-conjugated secondary antibodies (1:5000, Rockland Immunochemicals, USA) were used to visualize blots using Odyssey laser scanning system (LI-COR Inc., USA). The band intensities of each protein in control and with treatments were measured using NIH Image J software and expressed as relative values normalized to β-actin.
Rac1 activity pull-down assay
Assays were performed using a Rac1 activation assay kit, according to the manufacturer's recommendations (Millipore, USA). Cells were lysed in Mg 2+ lysis buffer containing protease inhibitors and phosphatase inhibitors, followed by centrifugation to remove cell debris. Equal amounts (0.5 mg) of total protein were incubated with 10 μl of agarose-conjugated p21-binding domain of PAK1, which binds activated Rac1, for 1 h at 4°C. The agarose beads were washed three times in lysis buffer, resuspended in 20 μl 4× SDS loading buffer, and boiled for 10 min. Active (GTP-bound) Rac1 and total Rac1 were analyzed by Western blotting.
Immunocytochemistry
The co-cultures of Treg cells and VM neurons were washed with 0.01 M PBS to remove the suspended Treg cells. The remaining VM cells or VM neurons were fixed with 4% PFA, washed three times with 10 mM PBS, and incubated for 40 min at room temperature in 10 mM PBS containing 10% normal goat serum (Gibco, USA) and 0.3% Triton X-100. The VM cells or VM neurons were incubated with primary antibodies For co-expression of TH and SIRPA/CD47, or co-expression of Foxp3 and SIRPA/CD47, the co-cultures of Treg cells and VM neurons were fixed with 4% PFA, washed three times with 10 mM PBS, and incubated for 40 min at room temperature in 10 mM PBS containing 10% normal goat serum (Gibco, USA) and 0.3% Triton X-100. Both the cells were co-incubated with primary antibodies against TH (1:400, Millipore, USA) and SIRPA ( 
Quantization of cytokine levels by enzyme-linked immunosorbent assay (ELISA)
TGF-β1 and IL-10 levels in supernatants of VM neuron cultures in lower chamber of transwell coculture were quantified by ELISA kits according to the manufacturer's instruction (eBioscience, USA). Briefly, 50 μl of supernatants were added to the ELISA plate, which was incubated for 2 h at room temperature. After washing, 100 μl of respective HRP-conjugated IgG polyclonal antibody was added to each well of the ELISA plate, which was incubated for 2 h. After 30 min of incubation with 100 μl of substrate solution at room temperature protected from light, 100 μl of stop solution was added, and optical density was determined using a multi-mode microplate reader (Bio Tek, USA) at 450 nm. A standard curve was plotted from mean absorbance of each standard sample and the cytokine levels were calculated according to the standard curve.
Time-lapse video microscopy
Treg cells and VM neurons were prepared as described above. Treg cells were incubated with anti-CD47 antibody (1:100, Abcam, UK) and VM neurons were cultured with anti-SIRPA antibody (1:100, Abcam, UK) both in PBS containing 1% bovine serum albumin at 37°C for 1 h, followed by incubation with appropriate Alexa Fluor-conjugated secondary antibodies (1:200, Molecular Probes, USA). After staining, both SIRPAlabeled VM neurons and CD47-labeled Treg cells were transferred to a co-culture chamber filled with 1.5 ml of complete DMEM medium. The co-culture chamber was placed under a microscope (Leica AF6000, Germany) connected to a digital camera and an incubator. Images were taken every 20 s at a magnification of 200× for up to 6 h using automated software.
Construction and transfection of CD47-miRNA expression vector
CD47-miRNA expression vector (pcDNA/miR-CD47; Invitrogen, USA) was constructed and transfected into Treg cells using nucleofection technology (Amaxa biosystems, Germany). The transfection protocol followed the instructions of mouse T cell nucleofector kit (Amaxa Biosystems, Germany). Briefly, after incubated with anti-CD3 and anti-CD28 for 48 h, Treg cells were resuspended in 100 μl of T cell nucleofector solution. Plasmid of 4 μg was added to 100 μl of 5 × 10
6 Treg cell suspension. The mixtures were subsequently transferred to an electroporation cuvette, which was placed in the nucleofection device (Amaxa Biosystems, Germany). After nucleofection of these cells were accomplished using X-001 program, the samples were immediately transferred to 24-well plates containing 2 ml pre-warmed media. Interference efficiency was assessed by Western blotting analysis at 48 h after the transfection. The sequences of the single-stranded oligonucleotides targeting CD47 were as follows: Huang (Fig. 1A) . In contrast, the treatments with MPP 
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NeuN
+ cell number (Fig. 1A) .
To show glial mediator changes accompanied by the dopaminergic neuronal number alterations, we examined the expression of the pro-inflammatory cytokines TNF-α and IL-1β and the neurotrophic factors IGF-1 and GDNF in VM cell cultures. MPP + upregulated TNF-α and IL-1β expression at mRNA and protein levels, but downregulated IGF-1 and GDNF expression (Fig. 1B and C) . Treg cells prevented the MPP + -induced disorders in expression of the pro-inflammatory cytokines and the neurotrophic factors (Fig. 1B and C) . Treg cell treatment alone did not significantly alter TNF-α, IL-1β, IGF-1 or GDNF expression compared with untreated control (Fig. 1B and C) .
Treg cells do not significantly prevent MPP+-induced dopaminergic neuronal loss in transwell co-culture
The transwell cell culture chamber containing Treg cells was placed into the VM neuron culture plate. The co-culture blocked Treg cells to directly act on the neurons, but cytokines secreted from Treg cells were able to infiltrate into the lower neuron cultures to affect the neurons. As expected, in the lack of Treg cell treatment, the cytokines TGF-β1 and IL-10 were not able to be detected in the supernatants of lower VM neuron cultures regardless of control or MPP + treatment ( Fig. 2A) . In contrast, in Treg cell co-culture with VM neurons via the transwell system, both TGF-β1 and IL-10 levels significantly increased in the supernatants of lower VM neuron cultures treated by MPP + (Fig. 2A) . Importantly, MPP (Fig. 2B ).
CD47 and SIRPA are expressed by Treg cells and/or dopaminergic neurons and mediate a direct contact of Treg cells with the neurons
Since Treg cell cytokines did not prevent MPP + -induced dopaminergic neuronal loss, a Treg-to-neuron cell contact protection via an interaction between the two transmembrane proteins CD47 and SIRPA was examined. CD47 was expressed by both TH + cells and Foxp3 + cells in VM neuron and Treg cell co-cultures, while SIRPA was expressed only by TH + cells (Fig. 3A) . Notably, a dynamic contact of CD47-stained Treg cells with SIRPA-stained VM neurons was captured by live cell imaging system (Fig. 3B and for online suppl. material, see www.karger.com/doi/10.1159/000464388). 
CD47-SIRPA interaction mediates Treg cell protection against MPP+-induced dopaminergic neuronal loss and neuronal apoptosis
Treg-to-neuron cell contact protection depending on CD47-SIRPA interaction was assessed by silencing CD47 gene in Treg cells and silencing SIRPA gene in VM neurons, respectively. Both CD47 expression in Treg cells transfected with CD47-miRNA and SIRPA expression in VM neurons transfected with SIRPA-shRNA were downregulated, with respect to scrambled miRNA and shRNA sequences, respectively ( Fig. 4A and B 
TH + NeuN + cell loss (Fig. 4C) . Silencing CD47 gene in Treg cells reduced the protection of Treg cells against MPP + neurotoxicity (Fig. 4C) . Moreover, in SIRPA-knockdown VM neurons, Treg (Fig. 4C and D) .
In addition to assessing dopaminergic neuronal number, the anti-apoptotic molecule Bcl-xL and the pro-apoptotic enzyme active caspase-3 were tested for confirming the Treg cell contact protection. As expected, MPP + downregulated Bcl-xL expression but upregulated active caspase-3 expression in VM neurons (Fig. 5A) . Treg cells prevented the MPP + -induced changes in expression of the apoptosis-related markers (Fig. 5A) . Significantly, silencing CD47 gene in Treg cells reduced the protection of Treg cells against MPP + -induced neuronal apoptosis (Fig. 5A) . Similarly, MPP + downregulated Bcl-xL expression and upregulated active caspase-3 expression in SIRPA-knockdown VM neurons (Fig. 5B) . Although the combined treatment with Treg cells and MPP + increased Bcl-xL expression and decreased active caspase-3 expression compared with MPP + treatment alone in SIRPA-knockdown VM neurons, it did not recover both the protein expression to a control level (Fig. 5B) . This result showed that silencing SIRPA gene in VM neurons reduced Treg cell protection against MPP + -induced neuronal apoptosis.
Treg cells activate neuronal Rac1/Akt signaling via CD47-SIRPA interaction
A CD47-SIRPA downstream signaling pathway Rac1/Akt in VM neurons was examined to determine whether this pathway is involved in Treg cell neuroprotection. Activation level of Rac1 was assessed by a ratio between densitometric values of GTP-bound and total Rac1; and activation level of Akt was assessed by Akt phosphorylation level normalized to β-actin. Treg cells enhanced both Rac1 and Akt activation in VM neurons in either the presence or the absence of MPP + (Fig. 6A) . Silencing CD47 gene in Treg cells reduced the effects of Treg cells activating neuronal Rac1/Akt signaling pathway regardless of the presence or the absence of MPP + (Fig. 6A ). In addition, although Treg cells still activated Rac1/Akt signaling pathway in SIRPA-knockdown neurons in the presence or the absence of MPP + , the ability of Treg cells to activate Rac1/Akt signaling in SIRPA-knockdown neurons was 2.5-fold lower than in intact neurons (Fig. 6B) . + cell number compared with untreated control (Fig. 7A) . In contrast, these same treatments did not affect TH -NeuN + cell number (Fig. 7A) . Moreover, as shown above, both the downregulated Bcl-xL expression and the upregulated active caspase-3 expression in VM neurons caused by MPP + were prevented by Treg cells (Fig. 7B) . Importantly, NSC23766 impaired the Treg cell protection against MPP + -induced neuronal apoptosis (Fig. 7B) . Simultaneously, neuronal Akt activation by Treg cells was inhibited by NSC23766 (Fig. 7B ). NSC23766 exposure alone did not significantly alter neuronal apoptosis and Akt activation compared with untreated control (Fig. 7B) .
Inhibiting neuronal
Discussion
In the present study, Treg cells prevented MPP + -induced dopaminergic neuronal loss, pro-inflammatory cytokine upregulation, and neurotrophic factor downregulation in VM cell cultures that included neurons and glia, demonstrating that Treg cells exert neuroprotective effect. The pro-inflammatory cytokines TNF-α and IL-1β as well as the neurotrophic factors IGF-1 and GDNF are predominantly expressed by glia [35, 36] . Therefore, the prevention of the glial mediator disorders by Treg cells suggests that Treg cells inhibit glial activation and inflammatory response. As a support, Reynolds et al. [6] have shown that Treg cells mediate neuroprotection through modulation of microglial oxidative stress and inflammation. Indeed, Treg cells, as important immunosuppressive cells, are better understood to inhibit glial activation and inflammatory response to exert neuroprotective property. As a comparison, our recent work demonstrated that CD4 +
CD25
-Th17 cells exacerbated MPP + -induced dopaminergic neuronal loss and pro-inflammatory/neurotrophic factor disorders in VM cell cultures [7] . These results show that the two T cell subsets CD4 +
-Th17 and CD4
Treg have opposite effects on dopaminergic neuronal survival by a pro-inflammatory and anti-inflammatory property, respectively. In addition to the indirect action of Treg cells on neurons via the glial mediation, we hypothesized that Treg cells directly act on dopaminergic neurons to perform neuroprotection. The cytokines TGF-β1 and IL-10 secreted from Treg cells are important in transmitting Treg cell immunosuppressive effects [10, 37] . However, in transwell coculture of Treg cells and VM neurons, TGF-β1 and IL-10 released from Treg cells did not significantly protect dopaminergic neurons against MPP + toxicity in the current study. The findings suggest that Treg cells do not depend on their cytokines to exert the direct neuroprotective effect. In fact, we have recently demonstrated that microglia are a required target for TGF-β1 neuroprotection against MPP + toxicity [19] . Thus, a cell-to-cell (Treg-toneuron) communication with the aid of cell surface molecules becomes a key mechanism underlying Treg cell neuroprotection.
CD47 was expressed on both Treg cells and dopaminergic neurons, and SIRPA was expressed only on dopaminergic neurons in this study. These data are consistent with other reports that CD47 is expressed on virtually all cells, whereas SIRPA is predominantly -induced dopaminergic neuronal loss and neuronal cell apoptosis. These results demonstrate that CD47-SIRPA interaction is crucial in mediating Treg cell protection to dopaminergic neurons. CD47-SIRPA interaction is clearly important to homeostatic regulation of myeloid cell function, particularly these cells' phagocytic activity [41] . However, information on functions of CD47-SIRPA signaling pathway in the brain remains limited, although putative roles of CD47 and SIRPA have been addressed individually [16] . These various observations indicate that CD47-SIRPA signaling pathway might participate in regulation of hippocampus-dependent memory formation, of central responses to stress, and of the autonomic nervous system [16] . Here, we provide new evidence for CD47-SIRPA interaction between immune cells and neurons, establishing that the interaction of CD47 on Treg cells with SIRPA on dopaminergic neurons mediates Treg cell neuroprotection.
CD47/SIRPA downstream signaling involves Rac1/Akt pathway [16, 42] . This pathway plays an important role in regulating neuronal survival and inhibiting neuronal apoptosis [43, 44] . Rac1 has been shown to promote cell survival via Akt [45] . In the present study, Treg cells activated neuronal Rac1/Akt signaling pathway, suggesting that Rac1/Akt pathway is involved in Treg cell action on neurons. Further investigation revealed that either silencing CD47 in Treg cells or silencing SIRPA in neurons reduced the Treg-induced neuronal Rac1/ Akt activation. These findings indicate that neuronal Rac1/Akt activation at least in part depends on CD47-SIRPA interaction between Treg cells and neurons. The inhibition of Treg-induced neuronal Rac1/Akt activation with NSC23766 reduced the neuroprotection of Treg cells against MPP + toxicity. These results suggest that neuronal Rac1/Akt activation depending on the interaction of CD47 and SIRPA is an intracellular signaling mechanism for Treg cell neuroprotection.
In summary, Treg cells protect dopaminergic neurons against MPP + toxicity by inhibiting glial pro-inflammatory response. In addition to the indirect action of Treg cells on neurons via the glial mediation, Treg cells can directly protect dopaminergic neurons against MPP + -induced neuronal loss and apoptosis. This direct neuroprotection by Treg cells does not depend on the cytokines TGF-β1 and IL-10 secreted from Treg cells, but depends on a cellto-cell (Treg-to-neuron) contact mechanism. Interaction of CD47 on Treg cells with SIRPA on dopaminergic neurons contributes to the contact protection of Treg cells to the neurons. Simultaneously, the CD47-SIRPA interaction between Treg cells and neurons activates neuronal Rac1/Akt signaling pathway and this pathway mediates Treg cell neuroprotection. These findings provide a new insight into promotion of Treg-to-neuron intercellular communication as a therapeutic strategy for PD.
